Advertisement
Research Article

Second Generation Sequencing of the Mesothelioma Tumor Genome

  • Raphael Bueno,

    Affiliations: The International Mesothelioma Program, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

    X
  • Assunta De Rienzo,

    Affiliations: The International Mesothelioma Program, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

    X
  • Lingsheng Dong,

    Affiliations: The International Mesothelioma Program, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

    X
  • Gavin J. Gordon,

    Affiliations: The International Mesothelioma Program, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

    X
  • Colin F. Hercus,

    Affiliation: Synamatix, Kuala Lumpur, Malaysia

    X
  • William G. Richards,

    Affiliations: The International Mesothelioma Program, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

    X
  • Roderick V. Jensen,

    Affiliation: Department of Biological Sciences, Virginia Tech, Blacksburg, Virginia, United States of America

    X
  • Arif Anwar,

    Affiliation: Synamatix, Kuala Lumpur, Malaysia

    X
  • Gautam Maulik,

    Affiliations: The International Mesothelioma Program, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

    X
  • Lucian R. Chirieac,

    Affiliations: The International Mesothelioma Program, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

    X
  • Kim-Fong Ho,

    Affiliation: Synamatix, Kuala Lumpur, Malaysia

    X
  • Bruce E. Taillon,

    Affiliation: 454 Life Sciences, Inc., Branford, Connecticut, United States of America

    X
  • Cynthia L. Turcotte,

    Affiliation: 454 Life Sciences, Inc., Branford, Connecticut, United States of America

    X
  • Robert G. Hercus,

    Affiliation: Synamatix, Kuala Lumpur, Malaysia

    X
  • Steven R. Gullans,

    Affiliation: Excel Medical Ventures, Boston, Massachusetts, United States of America

    X
  • David J. Sugarbaker mail

    dsugarbaker@partners.org

    Affiliations: The International Mesothelioma Program, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

    X
  • Published: May 13, 2010
  • DOI: 10.1371/journal.pone.0010612

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.